Noncoding RNA as Diagnostic and Prognostic Biomarkers in Cerebrovascular Disease-Reference-Cited by-同舟云学术

Noncoding RNA as Diagnostic and Prognostic Biomarkers in Cerebrovascular Disease

Published:2022-04-19 Issue: Volume:2022 Page:1-12
ISSN:1942-0994
Container-title:Oxidative Medicine and Cellular Longevity
language:en
Short-container-title:Oxidative Medicine and Cellular Longevity

Author:

Weng Ruiyuan¹²³⁴,Jiang Zhiwen¹²³⁴,Gu Yuxiang¹²³⁴^ORCID

Affiliation:

1. Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, China

2. Neurosurgical Institute of Fudan University, China

3. Shanghai Clinical Medical Center of Neurosurgery, China

4. Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, China

Abstract

Noncoding RNAs (ncRNAs), such as microRNAs, long noncoding RNAs, and circular RNAs, play an important role in the pathophysiology of cerebrovascular diseases (CVDs). They are effectively detectable in body fluids, potentially suggesting new biomarkers for the early detection and prognosis of CVDs. In this review, the physiological functions of circulating ncRNAs and their potential role as diagnostic and prognostic markers in patients with cerebrovascular diseases are discussed, especially in acute ischemic stroke, subarachnoid hemorrhage, and moyamoya disease.

Funder

National Natural Science Foundation of China

Publisher

Hindawi Limited

Subject

Cell Biology,Aging,General Medicine,Biochemistry

Link

http://downloads.hindawi.com/journals/omcl/2022/8149701.pdf

Reference131 articles.

1. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Stroke in China: advances and challenges in epidemiology, prevention, and management

3. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells